Hormones and COVID-19
April 2023
in “
Mayo Clinic Proceedings
”
TLDR Estrogen may help improve COVID-19 outcomes, especially in women.
The document discusses the potential impact of hormones on COVID-19 prognosis, highlighting differences between testosterone and estrogen. Testosterone may influence COVID-19 severity, with men on androgen deprivation therapy showing reduced infection risk and milder symptoms. However, a retrospective study found no significant difference in COVID-19 outcomes related to testosterone therapy. In contrast, estrogen, particularly estradiol (E2), is suggested to play a significant role in enhancing the female immune response, potentially offering benefits in managing COVID-19. The document suggests that E2 supplementation in menopausal women could enhance immune function, supporting survival and health longevity. The findings emphasize the potential of hormone replacement therapy in influencing COVID-19 outcomes, particularly in women.